УМБАЛ „Царица Йоанна – ИСУЛ“ или както е известна ИСУЛ е университетска многопрофилна болница за активно лечение, намираща се в София, с адрес ул. Бяло море 8, Телефон: 02 9432170. Болницата е висок капацитет за обслужване на пациенти по спешност и на диагностично и терапевтично трудни случаи.

During the past decade, University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna ISUL EAD conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 18 clinical trials were completed, i.e. on average, 69.2% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 13 clinical trials were completed. i.e. 162.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna ISUL EAD" #1 sponsor was "Bayer" with 6 trials, followed by "Celgene" with 6 trials sponsored, "Shire" with 5 trials sponsored, "Amgen" with 4 trials sponsored and "Hoffmann-La Roche" with 4 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna ISUL EAD" #1 collaborator was "Parexel" with 2 trials as a collaborator, "Innovative Therapies For Children with Cancer Consortium" with 1 trials as a collaborator and "Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) - Study Design & Execution Collaborator" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna ISUL EAD" are "Ulcerative Colitis" (7 trials), "Crohn Disease" (3 trials), "Crohn's Disease" (3 trials), "Heart Failure" (3 trials) and "Breast Cancer" (2 trials). Many other conditions were trialed in "University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna ISUL EAD" in a lesser frequency.

Most popular intervention types in "University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna ISUL EAD" are "Drug" (31 trials), "Other" (8 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Ozanimod" (6 trials), "Ontamalimab" (4 trials), "Dexamethasone" (3 trials) and "Atezolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna ISUL EAD" are 33 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna ISUL EAD". undefined are not yet recruiting, 6 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna ISUL EAD, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna ISUL EAD, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".